RVMD ▲ +13.2% - Revolution Medicines, Inc.
$RVMD reported Q3 2026 EPS of -$1.90, beating the -$2.37 estimate by 19.8%. Revenue of $197.6M beat the $27.6M estimate by 617.0%.
04-NOV-2026 04:15 PM ET
Share this post
More filings for $RVMD
RVMD ▲ +10.6% - Revolution Medicines, Inc.Nov 4, 2026RVMD ▲ +12.2% - Revolution Medicines, Inc.Nov 4, 2026RVMD ▲ +12.2% - Revolution Medicines, Inc.Nov 4, 2026RVMD - Revolution Medicines, Inc. - SEC Filing Update (30-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 30, 2026RVMD ▲ +1.2% - Revolution Medicines, Inc.Oct 27, 2026RVMD ▲ +0.8% - Revolution Medicines, Inc.Oct 23, 2026
View full $RVMD filing history →💬 Comments
Loading comments…
Leave a comment